Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jun;93(6):882-4.
doi: 10.2105/ajph.93.6.882.

Field-delivered therapy increases treatment for chlamydia and gonorrhea

Katherine C Steiner  1 , Veronica Davila, Charlotte K Kent, Janice K Chaw, Lyn Fischer, Jeffrey D Klausner
Affiliations

Field-delivered therapy increases treatment for chlamydia and gonorrhea

Katherine C Steiner et al. Am J Public Health. 2003 Jun.

Abstract

In 1998, treatment completion was low among chlamydia and gonorrhea cases reported to the San Francisco Department of Public Health and assigned for treatment follow-up. To improve treatment completion among growing numbers of chlamydia and gonorrhea cases, the department implemented field-delivered therapy (FDT), a single-dose, directly observed therapy protocol for uncomplicated chlamydial and gonococcal infections. After the protocol was implemented in March 1999, the proportion of cases completing treatment increased significantly, from 61.8% in 1998 to 81.0% in 2000. The greatest increases in treatment completion were observed for females and individuals younger than 20 years old. FDT is an effective, feasible, and convenient way to reach and treat individuals who are unlikely to return for chlamydia and gonorrhea treatment.

PubMed Disclaimer

Figures

FIGURE 1—
FIGURE 1—
Percentage of chlamydia and gonorrhea cases treated before and after implementation of field- delivered therapy: San Francisco, 1998 to 2001.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Sexually Transmitted Diseases Surveillance, 2001. Atlanta, Ga: Centers for Disease Control and Prevention; September2002.
    1. Cates W, Wasserheit JN. Genital chalmydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol. 1991;164:1771–1781. - PubMed
    1. Sweet RL. Pelvic Inflammatory disease: etiology, diagnosis, and treatment. Sex Transm Dis. 1981;8(suppl 4): 308–315. - PubMed
    1. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75:3–17. - PMC - PubMed
    1. Korenromp EL, Sudaryo MK, de Vlas SJ, et al. What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? Int J STD AIDS. 2002;13:91–101. - PubMed

MeSH terms

Substances